臨床オンコロジー次世代シーケンシング市場、規模、シェア、動向、産業分析レポート：技術別、ワークフロー別、用途別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、臨床オンコロジー次世代シーケンシング（NGS）市場規模は2034年までに22億879万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

臨床オンコロジー次世代シーケンシング（NGS）は、腫瘍DNAとRNAの包括的な解析を可能にする高スループットゲノム技術であり、がんを促進する変異、コピー数の変異、遺伝子融合、その他の分子変化を同定します。この技術は、臨床医が実用的な分子標的を同定し、治療反応を予測し、かつてない精度で疾患の進行をモニタリングすることを可能にすることで、プレシジョン・オンコロジーに革命をもたらしています。

次世代シーケンシングは、新規バイオマーカーを同定し、遺伝子型をマッチさせた臨床試験に患者を登録することで、がん研究を促進します。その変革の可能性にもかかわらず、この技術は腫瘍の不均一性、データ解釈の複雑さ、コストの障壁などの課題に直面しています。しかし、シングルセルシーケンス、ロングリード技術、人工知能の進歩により、NGSの精度とアクセシビリティが向上し、市場成長の原動力となっています。

臨床オンコロジー次世代シーケンシング市場レポートハイライト

技術面では、ターゲットシーケンス＆リシーケンスセグメントは、費用対効果、カバレッジの深さの高さ、特定の遺伝子またはゲノム領域に焦点を当てる能力により、2024年の市場収益シェアの64.93%を占めました。

ワークフロー別では、がんゲノムを高精度で解析できる高スループット、高精度、高コスト効率のプラットフォームに対する需要の急増により、シーケンシングセグメントが2024年の市場売上シェアの57.03%を占めました。

アプリケーション別では、コンパニオン診断薬分野が2024年に71.83%の売上シェアを獲得して市場をリードしました。この優位性は、関連する遺伝子バイオマーカーを有するFDA承認抗がん剤の数が増加していることに起因しています。

最終用途別では、分散型検査やポイントオブケア診断へのシフトにより、診療所分野が今後数年間でCAGR 19.21%を記録すると予測されています。

2024年の世界の臨床オンコロジー次世代シーケンシング（NGS）市場では、北米が44.16%のシェアを占めました。この優位性は、がんの有病率の高さ、高度なヘルスケアインフラ、精密医療の強力な導入に起因します。

欧州市場は、がん患者の増加、政府の支援政策、ゲノム医療への投資の増加により、2034年にはかなりの市場シェアを占めると予測されます。

アジア太平洋地域の市場は、予測期間中に最も高いCAGRを記録すると予測されます。これは、がん負担の増加、ヘルスケアアクセスの改善、ゲノム医療への投資の増加によるものです。

世界の主要市場プレーヤーとしては、Agilent Technologies、Eurofins Scientific S.E.、F. Hoffmann-La Roche Ltd.、Illumina, Inc.、Myriad Genetics、Oxford Nanopore Technologies Ltd.、Pacific Bioscience、Perkin Elmer、Qiagen N.V.、Thermo Fisher Scientificなどが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の臨床オンコロジー次世代シーケンシング市場の洞察

• 市場スナップショット
• 臨床オンコロジー次世代シーケンシング市場力学
  • 促進要因と機会
    • 技術の進歩の加速、
    • ヘルスケア費の増加
  • 抑制要因と課題
    • 高コスト
• PESTEL分析
• 臨床オンコロジー次世代シーケンシング市場の動向
• バリューチェーン分析

第5章 世界の臨床オンコロジー次世代シーケンシング市場：技術別

• 主な調査結果
• イントロダクション
• 全ゲノム配列解析
• 全エクソームシークエンシング
• ターゲットシーケンシングとリシーケンシング

第6章 世界の臨床オンコロジー次世代シーケンシング市場：用途別

• 主な調査結果
• イントロダクション
• スクリーニング
• コンパニオン診断
• その他

第7章 世界の臨床オンコロジー次世代シーケンシング市場：ワークフロー別

• 主な調査結果
• イントロダクション
• プレシーケンス
• シーケンシング
• データ分析

第8章 世界の臨床オンコロジー次世代シーケンシング市場：最終用途別

• 主な調査結果
• イントロダクション
• 病院
• クリニック
• その他

第9章 世界の臨床オンコロジー次世代シーケンシング市場：地域別

• 主な調査結果
• イントロダクション
  • 臨床オンコロジー次世代シーケンシング市場評価：地域別、2020～2034年
• 北米
  • 北米：技術別、2020～2034年
  • 北米：用途別、2020～2034年
  • 北米：ワークフロー別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：技術別、2020～2034年
  • 欧州：用途別、2020～2034年
  • 欧州：ワークフロー別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：技術別、2020～2034年
  • アジア太平洋地域：用途別、2020～2034年
  • アジア太平洋地域：ワークフロー別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：技術別、2020～2034年
  • 中東・アフリカ：用途別、2020～2034年
  • 中東・アフリカ：ワークフロー別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：技術別、2020～2034年
  • ラテンアメリカ：用途別、2020～2034年
  • ラテンアメリカ：ワークフロー別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Agilent Technologies
• Eurofins Scientific S.E.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Myriad Genetics
• Oxford Nanopore Technologies Ltd.
• Pacific Bioscience
• Perkin Elmer
• Qiagen N.V.
• Thermo Fisher Scientific

List of Tables:

• Table 1 Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 2 Global Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 3 Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 4 Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 5 North America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 6 North America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 7 North America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 8 North America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 9 U.S.: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 10 U.S.: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 11 U.S.: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 12 U.S.: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 13 Canada: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 14 Canada: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 15 Canada: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 16 Canada: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 17 Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 18 Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 19 Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 20 Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 21 UK: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 22 UK: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 23 UK: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 24 UK: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 25 France: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 26 France: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 27 France: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 28 France: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 29 Germany: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 30 Germany: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 31 Germany: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 32 Germany: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 33 Italy: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 34 Italy: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 35 Italy: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 36 Italy: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 37 Spain: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 38 Spain: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 39 Spain: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 40 Spain: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 41 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 42 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 43 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 44 Netherlands: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 45 Russia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 46 Russia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 47 Russia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 48 Russia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 49 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 50 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 51 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 52 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 53 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 54 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 55 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 56 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 57 China: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 58 China: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 59 China: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 60 China: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 61 India: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 62 India: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 63 India: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 64 India: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 65 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 66 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 67 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 68 Malaysia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 69 Japan: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 70 Japan: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 71 Japan: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 72 Japan: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 73 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 74 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 75 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 76 Indonesia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 77 South Korea: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 78 South Korea: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 79 South Korea: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 80 South Korea: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 81 Australia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 82 Australia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 83 Australia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 84 Australia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 85 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 86 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 87 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 88 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 89 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 90 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 91 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 92 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 93 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 94 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 95 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 96 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 97 UAE: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 98 UAE: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 99 UAE: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 100 UAE: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 101 Israel: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 102 Israel: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 103 Israel: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 104 Israel: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 105 South Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 106 South Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 107 South Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 108 South Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 109 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 110 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 111 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 112 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 113 Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 114 Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 115 Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 116 Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 117 Mexico: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 118 Mexico: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 119 Mexico: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 120 Mexico: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 121 Brazil: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 122 Brazil: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 123 Brazil: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 124 Brazil: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 125 Argentina: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 126 Argentina: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 127 Argentina: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 128 Argentina: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• Table 129 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• Table 130 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• Table 131 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• Table 132 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Global Clinical Oncology Next Generation Sequencing Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Technology
• Figure 7. Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2024 & 2034 (USD Million)
• Figure 8. Market by Application
• Figure 9. Global Clinical Oncology Next Generation Sequencing Market, by Application, 2024 & 2034 (USD Million)
• Figure 10. Market by Workflow
• Figure 11. Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2024 & 2034 (USD Million)
• Figure 12. Market by End Use
• Figure 13. Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2024 & 2034 (USD Million)

The Clinical oncology next generation sequencing (NGS) market size is expected to reach USD 2,208.79 million by 2034, according to a new study by Polaris Market Research. The report "Clinical Oncology Next Generation Sequencing Market Share, Size, Trends, Industry Analysis Report By Technology (Whole Genome Sequencing, Whole Exome Sequencing), By Workflow, By Application, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical oncology next generation sequencing (NGS) is a high-throughput genomic technology that enables comprehensive analysis of tumor DNA and RNA to identify cancer-driving mutations, copy number variations, gene fusions, and other molecular alterations. This technology is revolutionizing precision oncology by allowing clinicians to identify actionable molecular targets, predict treatment responses, and monitor disease progression with unprecedented accuracy.

Next generation sequencing fuels cancer research by identifying novel biomarkers and enrolling patients in genotype-matched clinical trials. Despite its transformative potential, the technology faces challenges such as tumor heterogeneity, data interpretation complexity, and cost barriers. However, advancements in single-cell sequencing, long-read technologies, and artificial intelligence are enhancing NGS accuracy and accessibility, driving market growth.

Clinical Oncology Next Generation Sequencing Market Report Highlights

In terms of technology, the targeted sequencing & resequencing segment accounted for 64.93% of market revenue share in 2024 due to its cost-effectiveness, high depth of coverage, and ability to focus on specific genes or genomic regions.

Based on workflow, the sequencing segment held 57.03% of market revenue share in 2024 due to a surge in demand for high-throughput, accurate, and cost-efficient platforms capable of analyzing cancer genomes with increased precision.

In terms of application, the companion diagnostics segment led the market in 2024 by capturing 71.83% revenue share. This dominance is attributed to the rising number of FDA-approved cancer drugs with associated genetic biomarkers.

Based on end use, the clinics segment is projected to register a CAGR of 19.21% in the coming years, owing to the shift toward decentralized testing and point-of-care diagnostics.

North America accounted for a 44.16% share of the global clinical oncology next generation sequencing (NGS) market in 2024. This dominance is attributed to the high prevalence of cancer, advanced healthcare infrastructure, and strong adoption of precision medicine.

The market in Europe is projected to hold a substantial market share in 2034, owing to increasing cancer cases, supportive government policies, and rising investments in genomic medicine.

The market in Asia Pacific is expected to register the highest CAGR during the forecast period, owing to the rising cancer burden, improving healthcare access, and increasing investments in genomics.

A few global key market players include Agilent Technologies; Eurofins Scientific S.E.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Myriad Genetics; Oxford Nanopore Technologies Ltd.; Pacific Bioscience; Perkin Elmer; Qiagen N.V.; and Thermo Fisher Scientific.

Polaris Market Research has segmented the clinical oncology next generation sequencing market report on the basis of technology, workflow, application, end use, and region:

By Technology Outlook (Revenue, USD Million, 2020-2034)

Whole Genome Sequencing

Whole Exome Sequencing

Targeted Sequencing & Resequencing

By Workflow Outlook (Revenue, USD Million, 2020-2034)

Pre-Sequencing

Sequencing

Data Analysis

By Application Outlook (Revenue, USD Million, 2020-2034)

Screening

Sporadic Cancer

Inherited Cancer

Companion Diagnostics

Other

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Clinics

Laboratories

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Source
  • 3.2.1. Primary Source
  • 3.2.2. Secondary Source

4. Global Clinical Oncology Next Generation Sequencing Market Insights

• 4.1. Clinical Oncology Next Generation Sequencing Market - Market Snapshot
• 4.2. Clinical Oncology Next Generation Sequencing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Technological Advancements,
    • 4.2.1.2. Rising Healthcare Spending
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High cost
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Clinical Oncology Next Generation Sequencing Market Trends
• 4.6. Value Chain Analysis

5. Global Clinical Oncology Next Generation Sequencing Market, by Technology

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
• 5.3. Whole Genome Sequencing
  • 5.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Whole Genome Sequencing, by Region, 2020-2034 (USD Million)
• 5.4. Whole Exome Sequencing
  • 5.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Whole Exome Sequencing, by Region, 2020-2034 (USD Million)
• 5.5. Targeted Sequencing & Resequencing
  • 5.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Targeted Sequencing & Resequencing, by Region, 2020-2034 (USD Million)

6. Global Clinical Oncology Next Generation Sequencing Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
• 6.3. Screening
  • 6.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Screening, by Region, 2020-2034 (USD Million)
  • 6.3.2. Sporadic Cancer
    • 6.3.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Sporadic Cancer, by Region, 2020-2034 (USD Million)
  • 6.3.3. Inherited Cancer
    • 6.3.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Inherited Cancer, by Region, 2020-2034 (USD Million)
• 6.4. Companion Diagnostics
  • 6.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Companion Diagnostics, by Region, 2020-2034 (USD Million)
• 6.5. Others
  • 6.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Clinical Oncology Next Generation Sequencing Market, by Workflow

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
• 7.3. Pre-Sequencing
  • 7.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Pre-Sequencing, by Region, 2020-2034 (USD Million)
• 7.4. Sequencing
  • 7.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Sequencing, by Region, 2020-2034 (USD Million)
• 7.5. Data Analysis
  • 7.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Data Analysis, by Region, 2020-2034 (USD Million)

8. Global Clinical Oncology Next Generation Sequencing Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• 8.3. Hospitals
  • 8.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Hospitals, by Region, 2020-2034 (USD Million)
• 8.4. Clinics
  • 8.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Clinics, by Region, 2020-2034 (USD Million)
• 8.5. Others
  • 8.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Clinical Oncology Next Generation Sequencing Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Clinical Oncology Next Generation Sequencing Market Assessment, By Geography, 2020-2034 (USD Million)
• 9.3. Clinical Oncology Next Generation Sequencing Market - North America
  • 9.3.1. North America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • 9.3.2. North America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • 9.3.3. North America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • 9.3.4. North America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.3.5. Clinical Oncology Next Generation Sequencing Market - US
    • 9.3.5.1. US: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.5.2. US: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.3.5.3. US: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.3.5.4. US: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.3.6. Clinical Oncology Next Generation Sequencing Market - Canada
    • 9.3.6.1. Canada: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.6.2. Canada: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.3.6.3. Canada: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.3.6.4. Canada: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• 9.4. Clinical Oncology Next Generation Sequencing Market - Europe
  • 9.4.1. Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • 9.4.2. Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • 9.4.3. Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • 9.4.4. Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.5. Clinical Oncology Next Generation Sequencing Market - UK
    • 9.4.5.1. UK: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.5.2. UK: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.5.3. UK: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.5.4. UK: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.6. Clinical Oncology Next Generation Sequencing Market - France
    • 9.4.6.1. France: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.6.2. France: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.6.3. France: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.6.4. France: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.7. Clinical Oncology Next Generation Sequencing Market - Germany
    • 9.4.7.1. Germany: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.7.2. Germany: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.7.3. Germany: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.7.4. Germany: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.8. Clinical Oncology Next Generation Sequencing Market - Italy
    • 9.4.8.1. Italy: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.8.2. Italy: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.8.3. Italy: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.8.4. Italy: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.9. Clinical Oncology Next Generation Sequencing Market - Spain
    • 9.4.9.1. Spain: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.9.2. Spain: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.9.3. Spain: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.9.4. Spain: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.10. Clinical Oncology Next Generation Sequencing Market - Netherlands
    • 9.4.10.1. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.10.2. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.10.3. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.10.4. Netherlands: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.11. Clinical Oncology Next Generation Sequencing Market - Russia
    • 9.4.11.1. Russia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.11.2. Russia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.11.3. Russia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.11.4. Russia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4.12. Clinical Oncology Next Generation Sequencing Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.12.2. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.12.3. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.12.4. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• 9.5. Clinical Oncology Next Generation Sequencing Market - Asia Pacific
  • 9.5.1. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • 9.5.2. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • 9.5.3. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • 9.5.4. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.5. Clinical Oncology Next Generation Sequencing Market - China
    • 9.5.5.1. China: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.5.2. China: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.5.3. China: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.5.4. China: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.6. Clinical Oncology Next Generation Sequencing Market - India
    • 9.5.6.1. India: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.6.2. India: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.6.3. India: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.6.4. India: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.7. Clinical Oncology Next Generation Sequencing Market - Malaysia
    • 9.5.7.1. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.7.2. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.7.3. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.7.4. Malaysia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.8. Clinical Oncology Next Generation Sequencing Market - Japan
    • 9.5.8.1. Japan: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.8.2. Japan: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.8.3. Japan: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.8.4. Japan: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.9. Clinical Oncology Next Generation Sequencing Market - Indonesia
    • 9.5.9.1. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.9.2. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.9.3. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.9.4. Indonesia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.10. Clinical Oncology Next Generation Sequencing Market - South Korea
    • 9.5.10.1. South Korea: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.10.2. South Korea: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.10.3. South Korea: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.10.4. South Korea: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.11. Clinical Oncology Next Generation Sequencing Market - Australia
    • 9.5.11.1. Australia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.11.2. Australia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.11.3. Australia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.11.4. Australia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5.12. Clinical Oncology Next Generation Sequencing Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• 9.6. Clinical Oncology Next Generation Sequencing Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • 9.6.2. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • 9.6.3. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • 9.6.4. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.6.5. Clinical Oncology Next Generation Sequencing Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.5.2. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.6.5.3. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.6.5.4. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.6.6. Clinical Oncology Next Generation Sequencing Market - UAE
    • 9.6.6.1. UAE: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.6.2. UAE: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.6.6.3. UAE: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.6.6.4. UAE: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.6.7. Clinical Oncology Next Generation Sequencing Market - Israel
    • 9.6.7.1. Israel: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.7.2. Israel: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.6.7.3. Israel: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.6.7.4. Israel: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.6.8. Clinical Oncology Next Generation Sequencing Market - South Africa
    • 9.6.8.1. South Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.8.2. South Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.6.8.3. South Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.6.8.4. South Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.6.9. Clinical Oncology Next Generation Sequencing Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
• 9.7. Clinical Oncology Next Generation Sequencing Market - Latin America
  • 9.7.1. Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • 9.7.2. Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • 9.7.3. Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • 9.7.4. Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.7.5. Clinical Oncology Next Generation Sequencing Market - Mexico
    • 9.7.5.1. Mexico: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.5.2. Mexico: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.7.5.3. Mexico: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.7.5.4. Mexico: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.7.6. Clinical Oncology Next Generation Sequencing Market - Brazil
    • 9.7.6.1. Brazil: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.6.2. Brazil: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.7.6.3. Brazil: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.7.6.4. Brazil: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.7.7. Clinical Oncology Next Generation Sequencing Market - Argentina
    • 9.7.7.1. Argentina: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.7.2. Argentina: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.7.7.3. Argentina: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.7.7.4. Argentina: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.7.8. Clinical Oncology Next Generation Sequencing Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.8.2. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.7.8.3. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.7.8.4. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Agilent Technologies
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Eurofins Scientific S.E.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. F. Hoffmann-La Roche Ltd.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Illumina, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Myriad Genetics
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Oxford Nanopore Technologies Ltd.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Pacific Bioscience
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Perkin Elmer
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Qiagen N.V.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Thermo Fisher Scientific
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development